Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
Clinical trial NCT06321601 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06321601
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2027-07-18
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.